News

Ideas That Generate Results

World’s Biggest Generics Players Capture 40% of US Market!

Mar 27, 2015

Share |
According to a new research report by RNCOS entitled, US Generic Drug Market Outlook 2018”, the Generics industry in the US is highly competitive. Different companies compete with each other depending on the product categories, and within each product category, upon dosage strengths and drug delivery systems. In addition to product development, the US Generic industry is also being crippled with litigating complex patent issues. The competition is also on a part of revenues generated from the sales of Generic products. Accordingly, the level of market share, revenues and gross profit attributable to a particular generic product normally is related to the number of competitors in that particular product category including pricing and time of launch.
 
In order to thrive in the US market, major generic manufacturers such as Teva pharmaceuticals, Actavis, Mylan, Sandoz (Novartis), Endo pharma, Lupin Pharma, and Dr. Reddy's Laboratory etc have been introducing new products in a timely and cost-effective manner. The top notch players in the Generics market covering 40% share are Actavis, Sandoz (Novartis), Teva and Mylan with Actavis taking the lead. Additionally, rest 60% of the market comprises of Indian Companies such as Lupin pharma, Dr. Reddy Laboratory, Zydus Pharma, Sun Pharma which are generating significant revenues from US sales of their Generics products. Apart from these players, domestic firms like Endo Pharma, Amneal Pharma, Abbott laboratories are also trying to maintain a strong position in Generics segment.
 
The report is spread in over 100 pages and provides an in-depth research and rational analysis of the current status and future prospect of the US Generics industry. The report provides clear picture of Generics market, its growth, and drivers & challenges. In addition to this, the study further highlights emerging trends and developments which have been occurring in the US over the years, market potential of Generics in key therapeutic segments, competitive landscape and regulatory scenario, among other pointers. It also provides valuable information to pharmaceutical and generic drug companies and investors looking to enter in this market. Facts and figures regarding market size, growth, share, regulatory environment and trends in technology development have been thoroughly analyzed in the report to provide clients a comprehensive overview of the market.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM731.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


Media Citation

get in touch

Please fill-in the information below.